...
首页> 外文期刊>Journal of molecular graphics & modelling >Aldose reductase inhibitors for diabetic complications: Receptor induced atom-based 3D-QSAR analysis, synthesis and biological evaluation
【24h】

Aldose reductase inhibitors for diabetic complications: Receptor induced atom-based 3D-QSAR analysis, synthesis and biological evaluation

机译:醛糖还原酶抑制剂治疗糖尿病并发症:受体诱导的基于原子的3D-QSAR分析,合成和生物学评估

获取原文
获取原文并翻译 | 示例

摘要

Herein, atom-based 3D-QSAR analysis was performed using receptor-guided alignment of 46 flavonoid inhibitors of aldose reductase (ALR2) enzyme. 3D-QSAR models were generated in PHASE programme, and the best model corresponding to PLS factor four (QSAR(4)), was selected based on different statistical parameters (i.e., R-train(2), 0.96; Q(test)(2) 0.81; SD, 0.26). The contour plots of different structural properties generated from the selected model were utilized for the designing of five new congener molecules. These designed molecules were duly synthesized, and evaluated for their in vitro ALR2 inhibitory activity that resulted in the micromolar (IC50 < 22 mu M) activity of all molecules. Thus, the newly designed molecules having ALR inhibitory potential could be employed for the management of diabetic complications. (C) 2015 Elsevier Inc. All rights reserved.
机译:在此,基于原子的3D-QSAR分析是使用46种醛糖还原酶(ALR2)酶类黄酮抑制剂的受体导向比对进行的。在PHASE程序中生成了3D-QSAR模型,并根据不同的统计参数(即R-train(2),0.96; Q(test)(),选择了对应于PLS因子4(QSAR(4))的最佳模型2)0.81; SD,0.26)。由所选模型生成的不同结构特性的等高线图用于设计五个新的同类分子。这些设计好的分子被适当地合成,并评估了其在体外对ALR2的抑制活性,从而导致了所有分子的微摩尔(IC50 <22μM)活性。因此,可以将具有ALR抑制潜能的新设计的分子用于糖尿病并发症的管理。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号